We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-5.8%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$175M
AUM Growth
+$3.1M
Cap. Flow
+$14M
Cap. Flow %
7.98%
Top 10 Hldgs %
23.4%
Holding
176
New
43
Increased
22
Reduced
65
Closed
27

Top Buys

Rank Stock Value
1
LEN icon
Lennar Class A
LEN
+$2.35M
2
GEHC icon
GE HealthCare
GEHC
+$1.93M
3
H icon
Hyatt Hotels
H
+$1.88M
4
YUM icon
Yum! Brands
YUM
+$1.77M
5
ENS icon
EnerSys
ENS
+$1.39M

Sector Composition

Rank Sector Weight
1 Healthcare 20.61%
2 Industrials 19.75%
3 Technology 15.41%
4 Consumer Staples 13.62%
5 Consumer Discretionary 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
51
ConocoPhillips
COP
$170B
$1.24M 0.71%
10,360
-6,915
-40% -$803K
INVH icon
52
Invitation Homes
INVH
$16.3B
$1.22M 0.7%
38,594
PPG icon
53
PPG Industries
PPG
$23.3B
$1.22M 0.7%
+9,425
New +$1.32M
AVGO icon
54
Broadcom
AVGO
$1.62T
$1.19M 0.68%
+14,360
New +$1.24M
SPG icon
55
Simon Property Group
SPG
$66B
$1.18M 0.67%
10,925
-300
-3% -$35.1K
PRU icon
56
Prudential Financial
PRU
$41.2B
$1.17M 0.67%
12,364
-200
-2% -$18.9K
MCD icon
57
McDonald's
MCD
$179B
$1.17M 0.67%
4,432
QSR icon
58
Restaurant Brands International
QSR
$26.3B
$1.17M 0.67%
17,524
+10,425
+147% +$749K
CVX icon
59
Chevron
CVX
$427B
$1.14M 0.65%
6,750
-1,650
-20% -$267K
ORCL icon
60
Oracle
ORCL
$404B
$1.11M 0.64%
+10,530
New +$1.22M
MDC
61
DELISTED
M.D.C. Holdings, Inc.
MDC
$1.09M 0.62%
+26,446
New +$1.23M
CARR icon
62
Carrier Global
CARR
$45.8B
$1.08M 0.62%
19,628
-11,019
-36% -$606K
WASH icon
63
Washington Trust Bancorp
WASH
$765M
$1.06M 0.6%
40,224
-1,845
-4% -$52.7K
TKR icon
64
Timken Company
TKR
$8.08B
$1.05M 0.6%
14,350
+300
+2% +$24.3K
NOC icon
65
Northrop Grumman
NOC
$75.5B
$1.01M 0.58%
2,297
-200
-8% -$87.8K
WM icon
66
Waste Management
WM
$86.8B
$1.01M 0.58%
6,625
TFC icon
67
Truist Financial
TFC
$61.6B
$996K 0.57%
34,807
-4,298
-11% -$132K
CTAS icon
68
Cintas
CTAS
$79.6B
$986K 0.56%
8,200
+3,900
+91% +$486K
LHX icon
69
L3Harris
LHX
$46.5B
$964K 0.55%
5,535
-125
-2% -$23K
ON icon
70
ON Semiconductor
ON
$28.5B
$911K 0.52%
+9,800
New +$952K
LLY icon
71
Eli Lilly
LLY
$1.01T
$908K 0.52%
1,690
-105
-6% -$54.1K
SYK icon
72
Stryker
SYK
$108B
$847K 0.48%
+3,100
New +$889K
ELV icon
73
Elevance Health
ELV
$90.6B
$843K 0.48%
1,935
-1,190
-38% -$540K
ABBV icon
74
AbbVie
ABBV
$465B
$835K 0.48%
5,600
-333
-6% -$48.9K
SWK icon
75
Stanley Black & Decker
SWK
$13.4B
$827K 0.47%
+9,900
New +$917K

Similar funds

New England Research & Management's Q3 2023 Portfolio in Review

As of Q3 2023, New England Research & Management held 176 positions worth $175M, up 1.8% from $172M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management deployed $14M of net new capital in Q3 2023, opening 43 new positions and adding to 22 existing holdings. Its largest new stake was Lennar Class A: 20,014 shares worth $2.17M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amgen, an estimated $1.07M trimmed.

  • New England Research & Management's largest Q3 2023 buy was Lennar Class A: 20,014 shares worth $2.17M.
  • New England Research & Management added most to Amazon in Q3 2023, an estimated $1.26M increase.
  • New England Research & Management's biggest Q3 2023 reduction was Amgen, cutting an estimated $1.07M.
  • New England Research & Management fully exited Jacobs Solutions in Q3 2023, selling an estimated $3.18M.
  • New England Research & Management's ten largest holdings make up 23% of its $175M portfolio in Q3 2023.
  • New England Research & Management opened 43 new positions and closed 27 in Q3 2023.
  • New England Research & Management's portfolio value rose 1.8% quarter-over-quarter to $175M.

Based on New England Research & Management's 13F filing for Q3 2023, filed 10 Oct 2023.